Viteava Pharmaceuticals
The Canadian Technology Accelerator experience, a valuable path in the journey to build and grow a company Robert Foldes, Founder and CEO of Viteava Pharmaceuticals In addition to my role as founder/entrepreneur bringing all of the components together to build an innovative drug development company, there are many other essential contributors towards this effort from… Read…
ChemGreen Innovation
ChemGreen Innovation has developed and patented a diversified portfolio of clean-tech novel polymers and nano-materials focusing initially on antimicrobial, conductive, and magnetic properties.
Ayogo
Ayogo Health Inc., an emerging technology company that transforms the way consumers with chronic conditions engage with their own care, announced today a Series A investment of $2.5 million from a syndicate of investors
Oxalys Pharmaceuticals
Oxalys is developing drugs for neurodegenerative disease. We are a startup that spun out of MIT in 2011. Our first product will treat Huntington’s disease (HD)
2016 InBIA Accelerator Program of the Year Award goes to The Canadian Technology Accelerator in Boston (CTA@Boston)
Published by Rachele RyanPictured (L-R): Consul General David Alward, Christina Pomanski, Rachele Ryan, Erin Donahue, Christine Sarkisian, Senior Trade Commissioner Thierry Weissenburger, Christine Carr, Susan Ahern, & Hendrik Kuipers. The Canadian Technology Accelerator in Boston (CTA@Boston), has been awarded the International Business Innovation Association’s (InBIA) 2016 Accelerator Program of the Year Award. It was judged along with… Read…